265 related articles for article (PubMed ID: 15560958)
1. Plasma clozapine concentration coefficients of variation in a long-term study.
Diaz FJ; de Leon J; Josiassen RC; Cooper TB; Simpson GM
Schizophr Res; 2005 Jan; 72(2-3):131-5. PubMed ID: 15560958
[TBL] [Abstract][Full Text] [Related]
2. Intra-individual variation of clozapine and norclozapine plasma levels in clinical practice.
Turrion MC; Perez J; Bernardo M; Fernandez-Egea E
Rev Psiquiatr Salud Ment (Engl Ed); 2020; 13(1):31-35. PubMed ID: 31122757
[TBL] [Abstract][Full Text] [Related]
3. Clozapine: more than 900 mg/day may be needed.
Maccall C; Billcliff N; Igbrude W; Natynczuk S; Spencer EP; Flanagan RJ
J Psychopharmacol; 2009 Mar; 23(2):206-10. PubMed ID: 18515467
[TBL] [Abstract][Full Text] [Related]
4. Fluvoxamine reduces the clozapine dosage needed in refractory schizophrenic patients.
Lu ML; Lane HY; Chen KP; Jann MW; Su MH; Chang WH
J Clin Psychiatry; 2000 Aug; 61(8):594-9. PubMed ID: 10982203
[TBL] [Abstract][Full Text] [Related]
5. Weight gain during a double-blind multidosage clozapine study.
de Leon J; Diaz FJ; Josiassen RC; Cooper TB; Simpson GM
J Clin Psychopharmacol; 2007 Feb; 27(1):22-7. PubMed ID: 17224708
[TBL] [Abstract][Full Text] [Related]
6. Relationship between plasma concentrations of clozapine and norclozapine and therapeutic response in patients with schizophrenia resistant to conventional neuroleptics.
Spina E; Avenoso A; Facciolà G; Scordo MG; Ancione M; Madia AG; Ventimiglia A; Perucca E
Psychopharmacology (Berl); 2000 Jan; 148(1):83-9. PubMed ID: 10663421
[TBL] [Abstract][Full Text] [Related]
7. Plasma clozapine, norclozapine, and the clozapine:norclozapine ratio in relation to prescribed dose and other factors: data from a therapeutic drug monitoring service, 1993-2007.
Couchman L; Morgan PE; Spencer EP; Flanagan RJ
Ther Drug Monit; 2010 Aug; 32(4):438-47. PubMed ID: 20463634
[TBL] [Abstract][Full Text] [Related]
8. The significance of sampling time in therapeutic drug monitoring of clozapine.
Jakobsen MI; Larsen JR; Svensson CK; Johansen SS; Linnet K; Nielsen J; Fink-Jensen A
Acta Psychiatr Scand; 2017 Feb; 135(2):159-169. PubMed ID: 27922183
[TBL] [Abstract][Full Text] [Related]
9. Plasma concentrations of high-dose olanzapine in a double-blind crossover study.
Kelly DL; Richardson CM; Yu Y; Conley RR
Hum Psychopharmacol; 2006 Aug; 21(6):393-8. PubMed ID: 16850522
[TBL] [Abstract][Full Text] [Related]
10. Plasma clozapine and norclozapine in relation to prescribed dose and other factors in patients aged <18 years: data from a therapeutic drug monitoring service, 1994-2010.
Couchman L; Bowskill SV; Handley S; Patel MX; Flanagan RJ
Early Interv Psychiatry; 2013 May; 7(2):122-30. PubMed ID: 22747759
[TBL] [Abstract][Full Text] [Related]
11. Relationship between clinical efficacy and clozapine concentrations in plasma in schizophrenia: effect of smoking.
Hasegawa M; Gutierrez-Esteinou R; Way L; Meltzer HY
J Clin Psychopharmacol; 1993 Dec; 13(6):383-90. PubMed ID: 8120151
[TBL] [Abstract][Full Text] [Related]
12. CYP1A2 activity as measured by a caffeine test predicts clozapine and active metabolite steady-state concentrationin patients with schizophrenia.
Ozdemir V; Kalow W; Posner P; Collins EJ; Kennedy JL; Tang BK; Albers LJ; Reist C; Roy R; Walkes W; Afra P
J Clin Psychopharmacol; 2001 Aug; 21(4):398-407. PubMed ID: 11476124
[TBL] [Abstract][Full Text] [Related]
13. Plasma levels of clozapine and norclozapine in Mexican schizophrenia patients.
González-Esquivel DF; Castro N; Ramírez-Bermúdez J; Custodio V; Rojas-Tomé S; Castro-Román R; Jung-Cook H
Arzneimittelforschung; 2011; 61(6):335-9. PubMed ID: 21827043
[TBL] [Abstract][Full Text] [Related]
14. Estimating the size of the effects of co-medications on plasma clozapine concentrations using a model that controls for clozapine doses and confounding variables.
Diaz FJ; Santoro V; Spina E; Cogollo M; Rivera TE; Botts S; de Leon J
Pharmacopsychiatry; 2008 May; 41(3):81-91. PubMed ID: 18484549
[TBL] [Abstract][Full Text] [Related]
15. Unanticipated plasma concentrations in two clozapine-treated patients.
Alfaro CL; McClure RK; Vertrees JE; Benavides R
Ann Pharmacother; 2001 Sep; 35(9):1028-31. PubMed ID: 11573850
[TBL] [Abstract][Full Text] [Related]
16. Plasma clozapine and norclozapine in patients prescribed different brands of clozapine (Clozaril, Denzapine, and Zaponex).
Couchman L; Morgan PE; Spencer EP; Johnston A; Flanagan RJ
Ther Drug Monit; 2010 Oct; 32(5):624-7. PubMed ID: 20720516
[TBL] [Abstract][Full Text] [Related]
17. Plasma clozapine levels and clinical response in treatment-refractory Chinese schizophrenic patients.
Wong JO; Leung SP; Mak T; Ng RM; Chan KT; Hon-Kee Cheung H; Choi WK; Lai J; Wai-Kiu Tsang A
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Mar; 30(2):251-64. PubMed ID: 16316716
[TBL] [Abstract][Full Text] [Related]
18. Exploring low clozapine C/D ratios, inverted clozapine-norclozapine ratios and undetectable concentrations as measures of non-adherence in clozapine patients: A literature review and a case series of 17 patients from 3 studies.
Ruan CJ; Olmos I; Ricciardi C; Schoretsanitis G; Vincent PD; Anıl Yağcıoğlu AE; Eap CB; Baptista T; Clark SR; Fernandez-Egea E; Kim SH; Lane HY; Leung J; Maroñas Amigo O; Motuca M; Every-Palmer S; Procyshyn RM; Rohde C; Suhas S; Schulte PFJ; Spina E; Takeuchi H; Verdoux H; Correll CU; Molden E; De Las Cuevas C; de Leon J
Schizophr Res; 2024 Jun; 268():293-301. PubMed ID: 37487869
[TBL] [Abstract][Full Text] [Related]
19. Gender, age, smoking behaviour and plasma clozapine concentrations in 193 Chinese inpatients with schizophrenia.
Tang YL; Mao P; Li FM; Li W; Chen Q; Jiang F; Cai ZJ; Mitchell PB
Br J Clin Pharmacol; 2007 Jul; 64(1):49-56. PubMed ID: 17298477
[TBL] [Abstract][Full Text] [Related]
20. Clozapine and norclozapine concentrations in serum and plasma samples from schizophrenic patients.
Hermida J; Paz E; Tutor JC
Ther Drug Monit; 2008 Feb; 30(1):41-5. PubMed ID: 18223461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
